Dimitriou et al. perform multiomic profiling of patients with melanoma experiencing immunotherapy-associated toxicity and identify a targetable role for type III-associated immune responses with an increase in CD4+ T cells expressing IL-17A.
- Florentia Dimitriou
- Phil F. Cheng
- Reinhard Dummer
